LEAH MAGESTRO: Open Payments
NPI 1265174353 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,394 in 91 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $496 · 2025 $2,394
Food & beverage: $2,394
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $668 |
| GlaxoSmithKline, LLC. | 13 | $499 |
| GENZYME CORPORATION | 14 | $318 |
| Regeneron Healthcare Solutions, Inc. | 10 | $274 |
| Grifols USA, LLC | 6 | $142 |
| Merck Sharp & Dohme LLC | 4 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $82 |
| Mallinckrodt Hospital Products Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $35 |
Products named: DUPIXENT, NUCALA, BREZTRI, FASENRA, TRELEGY ELLIPTA, Prolastin-C Liquid, WINREVAIR, AIRSUPRA.
Industry payments across CO — which companies pay providers there.
